Evidence map›Paper›PMID 31892956›Full record

ArticleDiabetology & metabolic syndrome2019

MMP-2 salivary activity in type 2 diabetes mellitus patients.

Juan Antonio Arreguin-Cano, Brenda Ayerdi-Nájera, Arvey Tacuba-Saavedra, Napoleón Navarro-Tito, Alfonso Dávalos-Martínez, Abel Emigdio-Vargas, Elia Barrera-Rodríguez, Nubia Blanco-García, Gloria Gutiérrez-Venegas, Elías Ventura-Molina and 1 more

Open access · goldAbstract read
In one paragraph

Article in Diabetology & metabolic syndrome, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Juan Antonio Arreguin-CanoUnit of Clinical and Epidemiological Innovation of the State of Guerrero, Secretary of Health of the State of Guerrero, Av. Juan R. Escudero No. 158 Col. C.D. Renacimiento, 39715 Acapulco, Guerrero Mexico.ORCID 0000-0003-1292-9880
Brenda Ayerdi-NájeraUnit of Clinical and Epidemiological Innovation of the State of Guerrero, Secretary of Health of the State of Guerrero, Av. Juan R. Escudero No. 158 Col. C.D. Renacimiento, 39715 Acapulco, Guerrero Mexico.
Arvey Tacuba-SaavedraLaboratory of Cellular Biology of Cancer, School of Chemical Sciences-Biological, University Autonomy of Guerrero, Chilpancingo, Guerrero Mexico.
Napoleón Navarro-TitoLaboratory of Cellular Biology of Cancer, School of Chemical Sciences-Biological, University Autonomy of Guerrero, Chilpancingo, Guerrero Mexico.
Alfonso Dávalos-MartínezUnit of Clinical and Epidemiological Innovation of the State of Guerrero, Secretary of Health of the State of Guerrero, Av. Juan R. Escudero No. 158 Col. C.D. Renacimiento, 39715 Acapulco, Guerrero Mexico.
Abel Emigdio-VargasUnit of Clinical and Epidemiological Innovation of the State of Guerrero, Secretary of Health of the State of Guerrero, Av. Juan R. Escudero No. 158 Col. C.D. Renacimiento, 39715 Acapulco, Guerrero Mexico.
Elia Barrera-RodríguezUnit of Clinical and Epidemiological Innovation of the State of Guerrero, Secretary of Health of the State of Guerrero, Av. Juan R. Escudero No. 158 Col. C.D. Renacimiento, 39715 Acapulco, Guerrero Mexico.
Nubia Blanco-GarcíaUnit of Clinical and Epidemiological Innovation of the State of Guerrero, Secretary of Health of the State of Guerrero, Av. Juan R. Escudero No. 158 Col. C.D. Renacimiento, 39715 Acapulco, Guerrero Mexico.
Gloria Gutiérrez-Venegas2Laboratory of Biochemistry, School of Dentistry, National Autonomous University of Mexico, Mexico City, Mexico.
Elías Ventura-MolinaIntelligent Computing Laboratory, Computer Research Center, Polytechnic Institute in Computing, Mexico City, Mexico.
Gladys León-DorantesUnit of Clinical and Epidemiological Innovation of the State of Guerrero, Secretary of Health of the State of Guerrero, Av. Juan R. Escudero No. 158 Col. C.D. Renacimiento, 39715 Acapulco, Guerrero Mexico.
Universidad Autónoma de Guerrero · MXUniversidad Nacional Autónoma de México · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundType 2 diabetes mellitus (T2DM) and periodontitis are chronic inflammatory diseases with a bidirectional relationship. The uncontrolled levels of glucose in T2DM patients change the pathophysiology and balance of inflammatory mediators. Matrix Metalloproteinase-2 (MMP-2) is a zinc-dependent endopeptidase that is responsible for tissue remodeling and degradation of the extracellular matrix in periodontal tissue. Therefore, the uncontrolled levels of glucose in T2DM could lead to an imbalance in MMP-2 activity in saliva, favoring the development of periodontitis.

methodsNinety-seven T2DM patients from Hospital Dr. Donato Alarcon were included in the study. Following clinical examination, the patients were classified into four groups according to the presence and degree of periodontal disease and glycemic control. Blood and whole saliva samples (WSS) were collected from each patient. Blood samples were used for Hba1c and polymorphonuclear cells count determination, while WSS were used to determine MMP-2 activity, TIMP-1 and nitrite. MMP-2 activity was determined by zymography. TIMP-1 were determined by Western blotting, and nitric oxide (NO) levels were determined by the Griess method.

resultsOf the 97 patients with T2DM, 66 had periodontitis of different severities: 18 patients had mild periodontitis, 15 had moderate and 33 had severe. Salivary MMP-2 activity, HbA1c and TIMP-1 were positively correlated with the severity of periodontitis. On the other hand, the increase in HbA1c was negatively correlated with MMP-2 activity and quantity of TIMP-1 but was positively correlated with nitrite levels.

conclusionsT2DM with glycemic uncontrol conditions, distinct clinical alterations in periodontal tissue were identified, including a decrease in the gingival redness, increased the clinical attachment loss and imbalance of MMP-2/TIMP-1, as the possible causes of disorders promoting the progression of periodontitis. Accelerated periodontitis development with poor glycemic uncontrol likely results from the altered response of host defenses and decreased activity of polymorphonuclear cells. Taken together, these findings identify MMP-2 as a promising molecular market for periodontitis.

Indexed as

Diabetes mellitus type 2MMP-2PeriodontitisTIMP-1

Identifiers

PMID31892956
PMCPMC6937721
OpenAlexW2997389796

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.